Lercanidipine hydrochloride
CAS No. 132866-11-6
Lercanidipine hydrochloride ( Lercanidipine hydrochloride | Renovia | Vasodip | R 75 )
产品货号. M17950 CAS No. 132866-11-6
乐卡地平是二氢吡啶类钙通道阻滞剂。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥245 | 有现货 |
|
| 10MG | ¥349 | 有现货 |
|
| 25MG | ¥718 | 有现货 |
|
| 50MG | ¥1144 | 有现货 |
|
| 100MG | ¥1782 | 有现货 |
|
| 200MG | ¥2655 | 有现货 |
|
| 500MG | ¥4302 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥375 | 有现货 |
|
生物学信息
-
产品名称Lercanidipine hydrochloride
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述乐卡地平是二氢吡啶类钙通道阻滞剂。
-
产品描述Lercanidipine hydrochloride is a calcium channel blocker used in the treatment of hypertension.
-
体外实验Western Blot Analysis Cell Line:LPS/IFN-γ-induced VSMC Concentration:1 and 10 μM Incubation Time:24 h Result:Down-regulated LPS/IFN-γ-induced iNOS, MMP-2/-9, NF-kB expression and IkB-a phosphorylation. Decreased cytosolic HMGB1 fraction and extracellular HMGB1 release while increasing nuclear HMGB1 fraction.
-
体内实验Animal Model:Albino male Wistar rats, middle cerebral artery occlusion (MCAo) modelDosage:1, 0.5 and 0.25 mg/kg Administration:Intraperitoneal injection (i.p.), acute administrationResult:Showed neuroprotective effect in focal cerebral ischemic-reperfusion injury model, most effective dose was found to be at 0.5 mg/kg. Significantly attenuated percentage infarct volume, significantly improved the apparent diffusion coefficient. Declined MMP-9 activity significantly in all Lercanidipine treated groups till 240 min post-reperfusion, while MMP-2 activity was inhibited only till 120 min post-reperfusion. Decreased caspase-3 activity significantly in Lercanidipine 15 and 120 min post-reperfusion groups only. Exhibited significant reduction in caspase-9 activity in all groups except at 240 min post-reperfusion group.Animal Model:Male SHRs Dosage:1.92, 0.96, 0.48, 0.24 and 0.12 mg/kg Administration:Oral gavage (p.o.) for once Result:Increased the AOC values of mean arterial pressure in a dose-dependent manner (285.4 mmHg×hour for 1.92 mg) as well as decreased BP.
-
同义词Lercanidipine hydrochloride | Renovia | Vasodip | R 75
-
通路Endocrinology/Hormones
-
靶点AChR
-
受体Calcium Channel
-
研究领域Cardiovascular Disease
-
适应症——
化学信息
-
CAS Number132866-11-6
-
分子量648.19
-
分子式C36H41N3O6·HCl
-
纯度>98% (HPLC)
-
溶解度DMSO : 50 mg/mL 77.14 mM; H2O : < 0.1 mg/mL
-
SMILESCC1=C(C(C(=C(N1)C)C(=O)OC(C)(C)CN(C)CCC(c1ccccc1)c1ccccc1)c1cc(ccc1)[N+](=O)[O-])C(=O)OC.Cl
-
化学全称3-(1-((3,3-diphenylpropyl)(methyl)amino)-2-methylpropan-2-yl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate hydrochloride
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Gigant B, et al. Nature, 2005, 435(7041), 519-522.
产品手册
关联产品
-
Sodium Glucuronic Ac...
葡萄糖醛酸钠用于治疗肝炎和肝硬化。
-
Norarecoline hydroch...
去甲雷可林盐酸盐是一种毒蕈碱激动剂。
-
6-Ethoxydihydrosangu...
6-Ethoxydihydrosanguinarine 显示人血液乙酰胆碱酯酶 (HuAChE) 和人血浆丁酰胆碱酯酶 (HuBuChE) 抑制活性,IC50 值分别为 0.83 +/- 0.04 microM 和 4.20 +/- 0.19 microM。
021-51111890
购物车()
sales@molnova.cn

